An Inaugural Conference examining the fact and fiction of continuous manufacturing (CM) in the pharmaceutical industry.
The event will comprise two days of presentations from early adopters, one of which will take place at the National Formulation Centre in Sedgefield, UK, courtesy of the Centre for Process Innovation (CPI). There will also be an opportunity to visit Merck's Cramlington plant, where they recently installed a CDC 50, two ConsiGma™ Coaters, a Bruker Tandem and are utilising Siemens PAT technology.
The focus will be on the real-life experiences of existing users of CM technology, in the development and manufacture of oral solid dosage (OSD) form medicines.
Speakers from AstraZeneca – Bayer – CMAC – GSK – Janssen – MSD – RCPE – UCB Pharma – University of Sheffield will share invaluable and practical insights into 'going conti'.
EPR: A collaborative approach to continuous pharmaceutical manufacturing.
Throughout development to manufacturing, data is key to enable rapid response to market demand. The knowledge to enable intelligent decisions and the wisdom to optimise the complete product lifecycle is now at your fingertips. The latest release of PerceptiveAPC v8.0 delivers the next
PD2M May 18-20 2021 Virtual This is the place to explore what pharmaceutical manufacturing will look like in 2030, sharing discussions on new ways to develop medicines. How will Industry 4.0 enable us to respond to market demand, delivering flexible, modular manufacturing and bringing
18-19 May 2021 Virtual Perceptive Engineering - an Applied Materials company - is looking forward to participating in the Bionow Pharma Manufacturing Conference 2021. We will be joining AstraZeneca and Bristol Meyers Squibb in session 2, discussing the ‘Digitisation of Pharma